Legal Representation
Attorney
Tricia L. Schulz
USPTO Deadlines
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 14, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 14, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 9, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jul 9, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jul 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 9, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 7, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Feb 7, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 7, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Aug 15, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 11, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 11, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 11, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 29, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 27, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 27, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 27, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 3, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 3, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Nov 3, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 6, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 4, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 4, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 4, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 19, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 22, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 22, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 2, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 20, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 18, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 18, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 18, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 18, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 10, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 8, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Aug 23, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 31, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Biopharmaceutical preparations for the prevention and treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities
Class 042
Scientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic system fields
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"